These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 785150)

  • 41. [Case of allergic reaction to vincaton].
    Zelikov AKh; Danilov LN
    Klin Med (Mosk); 1974; 52(8):136-7. PubMed ID: 4278575
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical study of Pervincamine in a general medicine department].
    Vialette G; Argullos J
    Lyon Med; 1972 Apr; 227(8):773-6. PubMed ID: 4558729
    [No Abstract]   [Full Text] [Related]  

  • 43. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 44. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 45. [The small periwinkle at the service of medicine].
    Harlay A
    Infirm Fr; 1978 Nov; (199):5-6. PubMed ID: 251528
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of patients with initial manifestations of cerebral circulation insufficiency in vasomotor dystonias].
    Kanareĭkin KF; Manvelov LS
    Klin Med (Mosk); 1992; 70(5-6):56-60. PubMed ID: 1434406
    [No Abstract]   [Full Text] [Related]  

  • 47. [Synthesis of octahydroindolo [2,3-a] quinolizine derivatives].
    Xu JY; Zhu CL
    Yao Xue Xue Bao; 1986 Feb; 21(2):102-8. PubMed ID: 3751588
    [No Abstract]   [Full Text] [Related]  

  • 48. [Multi-center study of Cetal retard. Results of 60 studies].
    Jeske H; Lehrl S; Rudschies H; Schulte-Steinberg G
    ZFA (Stuttgart); 1982 Mar; 58(7):430-8. PubMed ID: 7090516
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical and electroencephalographic results of a double-blind test with vincamine (Pervincamine) in advanced cerebral sclerosis (author's transl)].
    Mikus P; Polák O; Ochsenreither AM
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):39-49. PubMed ID: 4602891
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Report of a trial with Pervincamine Forte Retard in 50 cases of various otological disorders].
    Oudot J
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 May; 27(5):361-5. PubMed ID: 149837
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of the effect of vincamine teprosilate on behavioural performances of patients affected with chronic cerebrovascular disease.
    Casale R; Giorgi I; Guarnaschelli C
    Int J Clin Pharmacol Res; 1984; 4(4):313-9. PubMed ID: 6500778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency.
    Hadjiev D; Yancheva S
    Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The intravenous laser therapy of circulatory encephalopathy].
    Shapovalov VM; Podvigin AV; Opekunova GT; Storokha AA
    Voen Med Zh; 1996 Apr; 317(4):30-1. PubMed ID: 8754056
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic].
    Mars G; Nebuloni G
    G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664
    [No Abstract]   [Full Text] [Related]  

  • 57. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Delayed-action pervincamine forte in circulatory disorders of the posterior segment of the eye].
    Bregeat P; Ryzman P
    Rev Otoneuroophtalmol; 1975; 47(5):353-8. PubMed ID: 1215739
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease.
    Solti F; Iskum M; Czakó E
    Arzneimittelforschung; 1976; 26(10a):1945-7. PubMed ID: 1037221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.